IRhythm Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
August 01, 2024 at 10:11 pm
Share
iRhythm Technologies, Inc. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was USD 148.05 million compared to USD 124.13 million a year ago. Net loss was USD 20.11 million compared to USD 18.48 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to USD 0.61 a year ago.
For the six months, sales was USD 279.98 million compared to USD 235.57 million a year ago. Net loss was USD 65.77 million compared to USD 57.59 million a year ago. Basic loss per share from continuing operations was USD 2.12 compared to USD 1.89 a year ago.
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
IRHYTHM TECHNOLOGIES, INC. 
